The FDA granted breakthrough status to Cogent’s GIST drug combo after a trial showed it cut disease progression or death risk by 50% compared with current treatment.
Importance Rank:
1
The FDA granted breakthrough status to Cogent’s GIST drug combo after a trial showed it cut disease progression or death risk by 50% compared with current treatment.
Copyright © Louis Velazquez. All Rights Reserved.